MRNA COVD19 vaccine

( DrugBank: - / KEGG DRUG: - )

3 diseases

ID	Disease name (Link within this page)	Number of trials
49	Systemic lupus erythematosus	1
53	Sjogren syndrome	1

ID	Disease name (Link within this page)	Number of trials
271	Ankylosing spondylitis	1

49. Systemic lupus erythematosus

Clinical trials : 993 / Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04839315 (ClinicalTrials.gov)	February 15, 2021	5/4/2021	COVID-19 Vaccination in Rheumatic Disease Patients	Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases	Systemic Lupus Erythematosus;Sjogren's Syndrome;Inflammatory Myositis;Psoriatic Arthritis;Gout;Ankyl ...	Biological: mRNA COVD19 vaccine	Mayo Clinic	NULL	Terminated	18 Years	N/A	All	58	Early Phase 1	United States

Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04839315 (ClinicalTrials.gov)	February 15, 2021	5/4/2021	COVID-19 Vaccination in Rheumatic Disease Patients	Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases	Systemic Lupus Erythematosus;Sjogren's Syndrome;Inflammatory Myositis;Psoriatic Arthritis;Gout;Ankyl ...	Biological: mRNA COVD19 vaccine	Mayo Clinic	NULL	Terminated	18 Years	N/A	All	58	Early Phase 1	United States

Clinical trials : 574 / Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04839315 (ClinicalTrials.gov)	February 15, 2021	5/4/2021	COVID-19 Vaccination in Rheumatic Disease Patients	Immunological Consequences of COVID-19 Vaccination in Patients With Rheumatic Diseases	Systemic Lupus Erythematosus;Sjogren's Syndrome;Inflammatory Myositis;Psoriatic Arthritis;Gout;Ankyl ...	Biological: mRNA COVD19 vaccine	Mayo Clinic	NULL	Terminated	18 Years	N/A	All	58	Early Phase 1	United States